Dr. Robert J. Soiffer, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (1983)
- Years since graduation
- 43
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 154
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1983Medical school: New York University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
MA license 56125
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
Medical groups
- Dana-Farber Cancer Institute, Inc. (684 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 154
- Services billed
- 421
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 238 | 107 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 176 | 37 |
| Established patient office or other outpatient visit, 40-54 minutes | 80 | 51 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 40 | 15 |
| Established patient office or other outpatient visit, 20-29 minutes | 25 | 23 |
| Hospital discharge day management, more than 30 minutes | 17 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Jakafi (ruxolitinib phosphate) | 84 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Boston, MA | 65 |
| Acyclovir Other prescribers in Boston, MA | 53 |
| Rezurock (belumosudil mesylate) | 50 |
| Ursodiol Other prescribers in Boston, MA | 26 |
| Atovaquone | 20 |
| Prednisone Other prescribers in Boston, MA | 19 |
| Tacrolimus Other prescribers in Boston, MA | 15 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Boston, MA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 16 payments worth $23,861 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $21,150 |
|---|---|
| National Marrow Donor Program | $2,547 |
| Jazz Pharmaceuticals Inc. | $121 |
| AstraZeneca Pharmaceuticals LP | $43.25 |
| Consulting Fee | $21,150 |
|---|---|
| Travel and Lodging | $1,710 |
| Food and Beverage | $882 |
| Gift | $75.00 |
| Education | $43.25 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Aug 22, 2025 | Consulting Fee | $9,900 |
| E.r. Squibb & Sons, L.l.c. Apr 16, 2025 | Consulting Fee | $5,700 |
| E.r. Squibb & Sons, L.l.c. Aug 22, 2025 | Consulting Fee | $2,250 |
| E.r. Squibb & Sons, L.l.c. Apr 28, 2025 | Consulting Fee | $1,800 |
| E.r. Squibb & Sons, L.l.c. Apr 28, 2025 | Consulting Fee | $1,500 |
| National Marrow Donor Program May 15, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $758 |
| National Marrow Donor Program May 15, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $435 |
| National Marrow Donor Program Sep 25, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $224 |
| National Marrow Donor Program Oct 24, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $167 |
| National Marrow Donor Program Jun 6, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $127 |
All 12 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| National Marrow Donor Program Dec 1, 2025 | Gift in-kind | $75.00 |
| AstraZeneca Pharmaceuticals LP Nov 25, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
| National Marrow Donor Program Oct 24, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $167 |
| National Marrow Donor Program Sep 25, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $224 |
| E.r. Squibb & Sons, L.l.c. Aug 22, 2025 | Consulting Fee | $9,900 |
| E.r. Squibb & Sons, L.l.c. Aug 22, 2025 | Consulting Fee | $2,250 |
| National Marrow Donor Program Jun 6, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $127 |
| National Marrow Donor Program May 15, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $758 |
| National Marrow Donor Program May 15, 2025 | Travel and Lodging travel to MINNEAPOLIS, MN · in-kind | $435 |
| E.r. Squibb & Sons, L.l.c. Apr 28, 2025 | Consulting Fee | $1,800 |
| E.r. Squibb & Sons, L.l.c. Apr 28, 2025 | Consulting Fee | $1,500 |
| E.r. Squibb & Sons, L.l.c. Apr 16, 2025 | Consulting Fee | $5,700 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.